Perimeter Advances AI Breast Cancer Surgery With Claire
Toronto, Canada and Dallas, Texas, August 13, 2026 Perimeter Medical Imaging AI Inc. has announced that Intermountain Health has...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Toronto, Canada and Dallas, Texas, August 13, 2026 Perimeter Medical Imaging AI Inc. has announced that Intermountain Health has...
Caesarea, Israel, August 13, 2026 IceCure Medical Ltd., a developer of minimally invasive cryoablation technology for tumor treatment, has...
Salt Lake City, Utah, August 6, 2026 BlueWind Medical, Ltd. has received U.S. Food and Drug Administration (FDA) 510(k)...
BOSTON, June 23, 2026 CereVasc, Inc. has completed patient enrollment in its pivotal STRIDE clinical trial, marking a major...
TOKYO, Japan, May 26, 2026 Olympus Corporation has announced a definitive agreement to acquire BioProtect Ltd., an Israel-based medical...
